-
Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders
15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th a…
Continue Reading..... -
Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program
QF Entity Partners with Children’s Hospital of Philadelphia 14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hemat…
Continue Reading..... -
Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East
22 April 2024, Doha, Qatar – A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the…
Continue Reading..... -
First Arab Middle Eastern Genetics Research in Autism Going Global
Thanks to Qatar’s Sidra Medicine, we now have a better understanding of Middle Eastern Genetics and their Implications for ASD 1 April 2024, Doha, Qatar – On World Autism Awarene…
Continue Reading.....